(Q80051619)
Statements
Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring (English)
Angela D M Kashuba
Naser L Rezk
Rustin D Crutchley